Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Return on Capital Employed (2016 - 2025)

Capricor Therapeutics has reported Return on Capital Employed over the past 15 years, most recently at 0.53% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.53% for Q4 2025, down 14.0% from a year ago — trailing twelve months through Dec 2025 was 0.53% (down 14.0% YoY), and the annual figure for FY2025 was 0.48%, down 2.0%.
  • Return on Capital Employed for Q4 2025 was 0.53% at Capricor Therapeutics, up from 0.85% in the prior quarter.
  • Over the last five years, Return on Capital Employed for CAPR hit a ceiling of 0.38% in Q4 2024 and a floor of 3.57% in Q3 2023.
  • Median Return on Capital Employed over the past 5 years was 0.72% (2025), compared with a mean of 1.01%.
  • Biggest five-year swings in Return on Capital Employed: tumbled -271bps in 2023 and later skyrocketed 277bps in 2024.
  • Capricor Therapeutics' Return on Capital Employed stood at 0.55% in 2021, then crashed by -90bps to 1.04% in 2022, then crashed by -38bps to 1.44% in 2023, then skyrocketed by 73bps to 0.38% in 2024, then tumbled by -37bps to 0.53% in 2025.
  • The last three reported values for Return on Capital Employed were 0.53% (Q4 2025), 0.85% (Q3 2025), and 0.64% (Q2 2025) per Business Quant data.